Leveraging NGS-Based Workflows for Comprehensive Antibody Discovery Screening

October 15, 2024

Next-generation sequencing (NGS) has become a powerful tool in the discovery and development of antibodies and their various formats including e.g. nanobodies. NGS-based assays provide comprehensive insights into the immune repertoire and yield valuable information about library diversity, complexity, and clonal enrichment. However, the successful generation of clear insights from intricate NGS data necessitates advanced data processing, analysis, and management solutions.

This poster showcases the comprehensive processing and analysis of nanobody NGS libraries with Genedata Selector^®, a software solution for all NGS-based assays. The platform enables the identification of more specific high-affinity binders within a much larger sequence space, accelerating the R&D process.